CRDF Cardiff Oncology, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Cardiff Oncology, Inc. (CRDF) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on April 9, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Cardiff Oncology, Inc. (CRDF) (SEC CIK 1213037), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 7.01: Regulation FD Disclosure
- • Cardiff Oncology (CRDF) conducting third-party investor/partner meetings using updated corporate slide presentation
- • Presentation filed as Exhibit 99.1 — primary source for pipeline updates, data, or strategic positioning
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Cardiff Oncology, Inc. (CRDF) 8-K current reports disclosing material events.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 9, 2026 | — | — | — |
8-K | Apr 2, 2026 | — | — | — |
8-K | Feb 25, 2026 | — | Analysis | — |
10-K | Feb 24, 2026 | Dec 31, 2025 | — | |
8-K | Feb 24, 2026 | — | Analysis | — |
8-K | Jan 27, 2026 | — | — | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | — | |
10-Q | Jul 29, 2025 | Jun 30, 2025 | — | |
10-Q | May 8, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 2, 2024 | Mar 31, 2024 | — | |
10-K | Feb 29, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 2, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | — | |
10-Q | May 4, 2023 | Mar 31, 2023 | — | |
10-K | Mar 2, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 3, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 4, 2022 | Jun 30, 2022 | — | |
10-Q | May 5, 2022 | Mar 31, 2022 | — | |
10-K | Feb 24, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 4, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 5, 2021 | Jun 30, 2021 | — | |
10-Q | May 6, 2021 | Mar 31, 2021 | — |
Frequently Asked Questions
What are the latest CRDF SEC filings in 2026?
Cardiff Oncology, Inc. (CRDF) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on April 9, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did CRDF file its most recent 10-K annual report?
Cardiff Oncology, Inc. (CRDF) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view CRDF 10-Q quarterly reports?
Cardiff Oncology, Inc. (CRDF)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every CRDF 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has CRDF filed recently?
Cardiff Oncology, Inc. (CRDF)'s most recent 8-K was filed on April 9, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find CRDF insider trading activity (Form 4)?
SignalX aggregates every CRDF Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does CRDF file with the SEC?
Cardiff Oncology, Inc. (CRDF) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new CRDF filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Cardiff Oncology, Inc. (CRDF).
What is CRDF's SEC CIK number?
Cardiff Oncology, Inc. (CRDF)'s SEC CIK (Central Index Key) number is 1213037. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1213037 to look up all CRDF filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find CRDF return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Cardiff Oncology, Inc. (CRDF) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Cardiff Oncology, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 62+ filings.